Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D003864:Depression, Chemical; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D006220:Haloperidol / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D012054:Reinforcement, Psychology / Q000187:drug effects*; D012110:Reserpine / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D013890:Thiourea / Q000494:pharmacology; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*
D006892:Hydroxydopamines; D008781:Methyltyrosines; D013844:Thiazoles; D014149:Tranquilizing Agents; D010868:Pimozide; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase; D013890:Thiourea; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine